Advertisement
Experimental Study| Volume 34, ISSUE 1, P35-41, July 1974

Antiarrhythmic and circulatory effects of astra W36095

A new lidocaine-like agent
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Although lidocaine is an effective antiarrhythmic agent, it must be administered parenterally and its duration of activity is short. Astra W36095 has a basic chemical structure similar to that of lidocaine but has a plasma half-life of 8 to 12 hours after administration to conscious dogs. Ventricular arrhythmias were produced in unanesthetized dogs, using ameroid constrictors on the proximal left anterior descending and circumflex coronary arteries. Stable ectopic beats were completely suppressed with plasma levels of 15 to 30 μg/ml of W36095. The duration of effect was 0.25 to 5 hours. In anesthetized dogs, an effective antiarrhythmic concentration of W36095 produced some depression of cardiac function. Thus, W36095 appears to be a long-acting, orally absorbed antiarrhythmic agent requiring clinical trials and metabolic studies. In addition, the arrhythmia model provides a sensitive method for studying new antiarrhythmic drugs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kuller L
        • Cooper M
        • Perper J
        Epidemiology of sudden death.
        Arch Intern Med. 1972; 129: 714-719
        • Lown B
        • Wolf M
        Approaches to sudden death from coronary heart disease.
        Circulation. 1971; 44: 130-142
        • Cohen L
        • Rosenthal J
        • Horner D
        • et al.
        Plasma levels of lidocaine after intramuscular administration.
        Am J Cardiol. 1972; 29: 520-523
        • Zener JZ
        • Kerber RE
        • Spivack AP
        • et al.
        Blood lidocaine levels and kinetics following high dose intramuscular administration.
        Circulation. 1973; 46: 984-988
        • Marlon AM
        • Adams MH
        • Bates BL
        • et al.
        A simplified method for the in vitro calibration of electromagnetic flowmeters.
        Cardiovasc Res. 1973; 7: 290-296
        • Scott DB
        Blood levels of lidocaine following various routes of administration.
        in: Scott DB Julian DG Lidocaine in the Treatment of Ventricular Arrhythmias. E & S Livingstone, Edinburgh1971: 153-158
        • Stenson RE
        • Constantino RT
        • Harrison DC
        Interrelationships of hepatic blood flow, cardiac output and blood levels in man.
        Circulation. 1971; 43: 205-211